INTERNATIONAL PATENT: ASTELLAS PHARMA INC., アステラス製薬株式会社 FILES APPLICATION FOR "HETEROCYCLIC COMPOUND FOR INDUCING DEGRADATION OF KRAS PROTEIN"

GENEVA, Aug. 5 -- ASTELLAS PHARMA INC. (5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo1038411), アステラス製薬株式会社 (東京都中央区日本橋本町二丁目５番１号) filed a patent application (PCT/JP2025/001994) for "HETEROCYCLIC COMPOUND FOR INDUCING DEGRADATION OF KRAS PROTEIN" on Jan 23, 2025. With publication no. WO/2025/159142, the details related to the patent application was published on Jul 31, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization...